Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Equity Average (2019 - 2025)

Historic Equity Average for Health Catalyst (HCAT) over the last 7 years, with Q3 2025 value amounting to $339.7 million.

  • Health Catalyst's Equity Average fell 457.4% to $339.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $339.7 million, marking a year-over-year decrease of 457.4%. This contributed to the annual value of $366.1 million for FY2024, which is 755.16% down from last year.
  • As of Q3 2025, Health Catalyst's Equity Average stood at $339.7 million, which was down 457.4% from $362.2 million recorded in Q2 2025.
  • In the past 5 years, Health Catalyst's Equity Average ranged from a high of $535.7 million in Q4 2021 and a low of $272.4 million during Q2 2021
  • In the last 5 years, Health Catalyst's Equity Average had a median value of $374.7 million in 2023 and averaged $391.5 million.
  • Its Equity Average has fluctuated over the past 5 years, first surged by 8608.27% in 2021, then plummeted by 1925.95% in 2022.
  • Quarter analysis of 5 years shows Health Catalyst's Equity Average stood at $535.7 million in 2021, then dropped by 19.26% to $432.5 million in 2022, then fell by 13.37% to $374.7 million in 2023, then dropped by 3.88% to $360.1 million in 2024, then fell by 5.66% to $339.7 million in 2025.
  • Its Equity Average was $339.7 million in Q3 2025, compared to $362.2 million in Q2 2025 and $371.0 million in Q1 2025.